Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Gross Margin (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Gross Margin readings, the most recent being 24.0% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 21050.0% to 24.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 94.35%, a 12608.0% increase, with the full-year FY2025 number at 41.91%, up 23689.0% from a year prior.
  • Gross Margin hit 24.0% in Q4 2025 for Lucid Diagnostics, up from 41.42% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 678.56% in Q4 2023 to a low of 2435.85% in Q2 2023.
  • Median Gross Margin over the past 5 years was 65.43% (2024), compared with a mean of 237.2%.
  • The widest YoY moves for Gross Margin: up 210450bps in 2024, down -91306bps in 2024.
  • Lucid Diagnostics' Gross Margin stood at 100.0% in 2021, then changed by 0bps to 100.0% in 2022, then surged by 579bps to 678.56% in 2023, then plummeted by -135bps to 234.5% in 2024, then skyrocketed by 90bps to 24.0% in 2025.
  • The last three reported values for Gross Margin were 24.0% (Q4 2025), 41.42% (Q3 2025), and 30.25% (Q2 2025) per Business Quant data.